Clinical Trial Update: TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers. [Phase 1]

View source ↗

Summary

This completed Phase I study evaluated the pharmacokinetic interaction between lopinavir/ritonavir and TMC125 (rilpivirine) in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Edurant (rilpivirine)
• Kaletra (lopinavir)

Snippet

Sponsor: Tibotec Pharmaceuticals, Ireland | Conditions: HIV | Phase 1 | Status: COMPLETED